Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06441955
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-04
First Post:
2024-06-02
Brief Title:
Covid-19 Long Haul Preventative and Health Promotion Care Clinical Trial Acceleration Program
Sponsor:
Well- Konnect Healthcare Services and Research Firm
Organization:
Well- Konnect Healthcare Services and Research Firm
Study Overview
Official Title:
Covid-19 Long Haul Syndrome Undiagnosed Disorder Post Covid-19 Alternative Treatment Study
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
We are conducting a study on alternative treatments for patients who have received an current or previous positive COVID-19 diagnosis with mild-serve symptoms or undiagnosable condition after testing positive for severe acute COVID-19 infection and are experiencing long-haul symptoms The symptoms of long COVID can include extreme tiredness fatigue shortness of breath memory and concentration issues brain fog heart palpitations dizziness joint pain muscle aches cough headaches anxiety and depression
Its important to note that there are various other symptoms that individuals can experience after a COVID-19 infection such as loss of smell chest pain or tightness difficulty sleeping insomnia pins and needles depression anxiety tinnitus earaches nausea diarrhea stomach aches loss of appetite cough headaches sore throat and changes to the sense of smell or taste
To be included in the study participants must have had symptoms for more than 4 weeks The goal of the study is to measure biomarkers identify new ones through clinical trials and individualize and optimize treatment plans which may or may not include COVID-19 post-market antivirals vaccines and medical care
Its essential to conduct thorough clinical trials to understand the long-term effects of COVID-19 and to develop personalized treatment plans for individuals experiencing long-haul symptoms
Its important to note that there are various other symptoms that individuals can experience after a COVID-19 infection such as loss of smell chest pain or tightness difficulty sleeping insomnia pins and needles depression anxiety tinnitus earaches nausea diarrhea stomach aches loss of appetite cough headaches sore throat and changes to the sense of smell or taste
To be included in the study participants must have had symptoms for more than 4 weeks The goal of the study is to measure biomarkers identify new ones through clinical trials and individualize and optimize treatment plans which may or may not include COVID-19 post-market antivirals vaccines and medical care
Its essential to conduct thorough clinical trials to understand the long-term effects of COVID-19 and to develop personalized treatment plans for individuals experiencing long-haul symptoms
Detailed Description:
We are planning a comprehensive study to understand and address the long-term effects of COVID-19 You aim to recruit 25 to 100 participants who have tested positive or clinically diagnosed with COVID-19 regardless of whether they have received treatment with COVID-19 post-market antivirals vaccines or medical care The study will involve conducting intake eligibility assessments and providing available treatments for COVID-19 to address the core morbidities associated with long-haul COVID-19
Your plan also includes collecting data from diverse participants to define seven biomarker categories and create a prognosis indicator for COVID-19 symptoms using precision medicine methods The focus will be on neurological and respiratory symptoms affecting quality of life with a special emphasis on women and men who are prone to developing Post COVID-19 long-haul syndrome Additionally you have outlined a diversity plan to ensure representation from a wide range of demographics
Its clear that you are dedicated to addressing the impact of long-haul COVID-19 and are taking a comprehensive approach to understand and treat the persistent symptoms experienced by individuals post-COVID-19 infection
Your plan also includes collecting data from diverse participants to define seven biomarker categories and create a prognosis indicator for COVID-19 symptoms using precision medicine methods The focus will be on neurological and respiratory symptoms affecting quality of life with a special emphasis on women and men who are prone to developing Post COVID-19 long-haul syndrome Additionally you have outlined a diversity plan to ensure representation from a wide range of demographics
Its clear that you are dedicated to addressing the impact of long-haul COVID-19 and are taking a comprehensive approach to understand and treat the persistent symptoms experienced by individuals post-COVID-19 infection
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None